SNN
Get informed when a big investor buys or sells
+ FollowOvervalued by 41.3% based on the discounted cash flow analysis.
| Market cap | $11.44 Billion |
|---|---|
| Enterprise Value | $14.47 Billion |
| Dividend Yield | $0.79 (2.90%) |
| Earnings per Share | $1.46 |
| Beta | 0.69 |
| Outstanding Shares | 430,397,727 |
| P/E Ratio | 17.76 |
|---|---|
| PEG | 713.96 |
| Price to Sales | 1.0 |
| Price to Book Ratio | 2.32 |
| Enterprise Value to Revenue | 1.18 |
| Enterprise Value to EBIT | 8.12 |
| Enterprise Value to Net Income | 12 |
| Total Debt to Enterprise | 0.26 |
| Debt to Equity | 0.73 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.01%▼ 8.49% |
|---|---|
| Total Invested | $1.74M▼ 99.84% |
| Investors Holding | 10▼ 285.00% |
No data
Smith & Nephew plc, along with its subsidiaries, operates globally as a developer, manufacturer, marketer, and seller of medical technology. Its orthopaedic division offers knee implants for replacement procedures and hip implants for jo...